Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by indaknownewfie

V.CLAS.H

JessicaTaylor 888 newest basher acvount

18 posts bashing Kaly in just a couple of hours and you only joined SH today....

December 16, 2019

V.CLAS.H

RE:RE:Another interesting Tidbit from the recent MD&A

The extension means they have. See Dude51's post from earlier today: ...

December 16, 2019

V.CLAS.H

Kalytera mentioned here

https://www.healtheuropa.eu/stero-biotechs-past-present-future-medicinal...

December 13, 2019

V.CLAS.H

Europe needs CBD

https://stockhouse.com/news/newswire/2019/12/10/could-europe-s-cbd-need...

December 13, 2019

V.CLAS.H

Top cannabis stocks

Top Cannabis Stocks - Dec 3 to Dec 9, 2019 image: https://stockhouse.com...

December 13, 2019

V.CLAS.H

RE:RE:There is a finished product using it on patients

Couldnt qgree more and an insightful post. Thanks for sharing 

December 13, 2019

GRPOF

RE:Lets roll

Agreed, lets get rolling. Too many positive things happening to keep this SP...

December 12, 2019

V.CLAS.H

RE:Expect an announcement between Dec 13-Dec24th

Finally a post that makes a lot of sense instead of the persistent, constant...

December 12, 2019

GRPOF

New update!!!!!

Keep the great news coming  Dr. Chamberland and Co. 

December 10, 2019

GWPRF

RE:Kalytera Therapeutics

I think this would be a perfect company to either partner with or buy out...

December 5, 2019

V.CLAS.H

Kalytera mentioned here

https://pbs.twimg.com/media/EK9rzpUXkAg4FYi?format=png&name=small

December 5, 2019

GRPOF

TBP -TIME TO SHINE

https://www.healthgazette24.com/clinical-trials-in-advanced-cancer-patients...

December 5, 2019

GRPOF

TBP -TIME TO SHINE

https://www.healthgazette24.com/clinical-trials-in-advanced-cancer-patients...

December 5, 2019

GRPOF

RE:New investor here

Jordantrademark wrote: I like what I see! Great news, this is the kind of...

December 4, 2019

V.CLAS.H

RE:RE:"Kalytera spends $1-million on R&D in Q3 2019"

totally agree

December 4, 2019

GRPOF

Big close today???

We will have to see.

December 3, 2019

V.CLAS.H

Buying opportunity

Be fearful when others are greedy and be greedy when others are fearful...

December 2, 2019

V.CLAS.H

RE:I BELIEVE A DEAL IS IMMINENT !! - BY DEC 15th ! !

This is what investors need to focus on. Posted on Sedar in the Kalytera'...

December 1, 2019

V.CLAS.H

Most recent estimates at .30 cad

Good near term but I think we will surpass that. 

December 1, 2019

GRPOF

RE:Significance of Orphan Drug Status

Second drug from Tetra receiving Orphan Drug Status. When you are looking at...

December 1, 2019

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Royalties Inc.

Royalties Inc. C.RI

Royalties Inc. is focused on seeking cash flow generating royalty opportunities in various industries. While the Issuer’s ... view more »